Your browser doesn't support javascript.
loading
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham, Lital; Vendramini, Elena; Ge, Yubin; Goren, Yaron; Birger, Yehudit; Tijssen, Marloes R; McNulty, Maureen; Geron, Ifat; Schwartzman, Omer; Goldberg, Liat; Chou, Stella T; Pitman, Holly; Weiss, Mitchell J; Michaeli, Shulamit; Sredni, Benjamin; Göttgens, Berthold; Crispino, John D; Taub, Jeffrey W; Izraeli, Shai.
Afiliação
  • Shaham L; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel; Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel;
  • Vendramini E; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
  • Ge Y; Department of Oncology, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI;
  • Goren Y; Rosetta Genomics Ltd, Rehovot, Israel;
  • Birger Y; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel;
  • Tijssen MR; Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;
  • McNulty M; Division of Hematology/Oncology, Northwestern University, Chicago, IL;
  • Geron I; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
  • Schwartzman O; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
  • Goldberg L; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel;
  • Chou ST; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Pitman H; Department of Oncology, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI;
  • Weiss MJ; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Michaeli S; Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel; Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan, Israel; and.
  • Sredni B; Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel;
  • Göttgens B; Department of Haematology, Cambridge Institute for Medical Research and Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;
  • Crispino JD; Division of Hematology/Oncology, Northwestern University, Chicago, IL;
  • Taub JW; Department of Oncology, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Division of Pediatric Hematology and Oncology, Children's Hospital of Michigan, Detroit, MI.
  • Izraeli S; Childhood Leukemia Research Institute, Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;
Blood ; 125(8): 1292-301, 2015 Feb 19.
Article em En | MEDLINE | ID: mdl-25533034
ABSTRACT
Children with Down syndrome (DS) are at increased risk for acute myeloid leukemias (ML-DS) characterized by mixed megakaryocytic and erythroid phenotype and by acquired mutations in the GATA1 gene resulting in a short GATA1s isoform. The chromosome 21 microRNA (miR)-125b cluster has been previously shown to cooperate with GATA1s in transformation of fetal hematopoietic progenitors. In this study, we report that the expression of miR-486-5p is increased in ML-DS compared with non-DS acute megakaryocytic leukemias (AMKLs). miR-486-5p is regulated by GATA1 and GATA1s that bind to the promoter of its host gene ANK1. miR-486-5p is highly expressed in mouse erythroid precursors and knockdown (KD) in ML-DS cells reduced their erythroid phenotype. Ectopic expression and KD of miR-486-5p in primary fetal liver hematopoietic progenitors demonstrated that miR-486-5p cooperates with Gata1s to enhance their self renewal. Consistent with its activation of AKT, overexpression and KD experiments showed its importance for growth and survival of human leukemic cells. Thus, miR-486-5p cooperates with GATA1s in supporting the growth and survival, and the aberrant erythroid phenotype of the megakaryocytic leukemias of DS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Síndrome de Down / MicroRNAs / Eritropoese Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Síndrome de Down / MicroRNAs / Eritropoese Idioma: En Ano de publicação: 2015 Tipo de documento: Article